Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: July 2015

Chapter 9 - Restless legs syndrome

1.Allen, RP, Picchietti, D, Hening, WA, Trenkwalder, C, Walters, AS, Montplaisi, J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003 Mar;4(2):101–19. PubMed PMID: 14592341.
2.American Academy of Sleep Medicine. International classification of sleep disorders. 2nd ed. Westchester, IL.: American Academy of Sleep Medicine; 2005.
3.Allen, RP, Walters, AS, Montplaisir, J, Hening, W, Myers, A, Bell, TJ, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005 Jun 13;165(11):1286–92. PubMed PMID: 15956009.
4.Allen, RP, Bharmal, M, Calloway, M. Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord. 2011 Jan;26(1):114–20. PubMed PMID: 21322022.
5.Chokroverty, S. Introduction: Comorbid disorders and special populations. In: Hening, W, Allen, RP, Chokroverty, S, Earley, CJ, editors. Restless legs syndrome. Philadelphia: Saunders, Elsevier; 2009. p. 161–6.
6.Ekbom, KA. Restless legs syndrome. Neurology. 1960 Sep;10:868–73. PubMed PMID: 13726241.
7.Morgan, LK. Letter: Restless legs: precipitated by beta blockers, relieved by orphenadrine. Med J Aust. 1975 Nov 8;2(19):753. PubMed PMID: 1214686.
8.Lutz, EG. Restless legs, anxiety and caffeinism. J Clin Psychiatry. 1978 Sep;39(9):693–8. PubMed PMID: 690085.
9.Ginsberg, HN. Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawal. Am J Psychiatry. 1986 Jul;143(7):938. PubMed PMID: 3717447.
10.Derom, E, Elinck, W, Buylaert, W, van der Straeten, M. Which beta–blocker for the restless leg? Lancet. 1984 Apr 14;1(8381):857. PubMed PMID: 6143173.
11.Hoque, R, Chesson, AL Jr. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med. 2010 Feb 15;6(1):7983. PubMed PMID: 20191944. Pubmed Central PMCID: 2823282.
12.Trenkwalder, C, Paulus, W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010 Jun;6(6):337–46. PubMed PMID: 20531433.
13.Salminen, AV, Rimpila, V, Polo, O. Peripheral hypoxia in restless legs syndrome (Willis–Ekbom disease). Neurology. 2014 Apr 30. PubMed PMID: 24789861.
14.Rios Romenets, S, Dauvilliers, Y, Cochen De Cock, V, Carlander, B, Bayard, S, Galatas, C, et al. Restless legs syndrome outside the blood–brain barrier–exacerbation by domperidone in Parkinson’s disease. Parkinsonism Relat Disord. 2013 Jan;19(1):92–4. PubMed PMID: 22922159.
15.Blier, P, El Mansari, M. Serotonin and beyond: therapeutics for major depression. Philos Trans R Soc Lond B Biol Sci. 2013;368(1615):20120536. PubMed PMID: 23440470. Pubmed Central PMCID: 3638389.
16.Perez–Lloret, S, Rey, MV, Bondon–Guitton, E, Rascol, O, Montastruc, AJ, French Association of Regional Pharmacovigilance C. Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database. J Clin Psychopharmacol. 2012 Dec;32(6):824–7. PubMed PMID: 23131889.
17.Allen, RP, Earley, CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 1996 Apr;19(3):205–13. PubMed PMID: 8723377.
18.Stahl, SM. Antidepressants. In: Stahl, SM, editor. Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications. New York: Cambridge University Press; 2008. p. 511666.
19.Sanz–Fuentenebro, FJ, Huidobro, A, Tejadas–Rivas, A. Restless legs syndrome and paroxetine. Acta Psychiatr Scand. 1996 Dec;94(6):482–4. PubMed PMID: 9021005.
20.Page, RL, 2nd, Ruscin, JM, Bainbridge, JL, Brieke, AA. Restless legs syndrome induced by escitalopram: case report and review of the literature. Pharmacotherapy. 2008 Feb;28(2):271–80. PubMed PMID: 18225972.
21.Chou, KJ, Chen, PY, Huang, MC. Restless legs syndrome following the combined use of quetiapine and paroxetine. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1139–40. PubMed PMID: 20470847.
22.Buskova, J, Vorlova, T, Pisko, J, Sonka, K. Severe sleep-related movement disorder induced by sertraline. Sleep Med. 2012 Jun;13(6):769–70. PubMed PMID: 22440086.
23.Belli, H, Akbudak, M, Ural, C. Duloxetine-related galactorrhea and restless legs syndrome: a case report. Psychiatr Danub. 2013 Sep;25(3):266–7. PubMed PMID: 24048395.
24.Perroud, N, Lazignac, C, Baleydier, B, Cicotti, A, Maris, S, Damsa, C. Restless legs syndrome induced by citalopram: a psychiatric emergency? Gen Hosp Psychiatry. 2007 Jan-Feb;29(1):72–4. PubMed PMID: 17189751.
25.Ozturk, O, Eraslan, D, Kumral, E. Oxcarbazepine treatment for paroxetine-induced restless leg syndrome. Gen Hosp Psychiatry. 2006 May-Jun;28(3):264–5. PubMed PMID: 16675374.
26.Chang, CC, Shiah, IS, Chang, HA, Mao, WC. Does domperidone potentiate mirtazapine-associated restless legs syndrome? Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):316–8. PubMed PMID: 16309808.
27.Prospero-Garcia, KA, Torres-Ruiz, A, Ramirez-Bermudez, J, Velazquez-Moctezuma, J, Arana-Lechuga, Y, Teran-Perez, G. Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial. J Clin Psychiatry. 2006 Nov;67(11):1820. PubMed PMID: 17196069.
28.Agargun, MY, Kara, H, Ozbek, H, Tombul, T, Ozer, OA. Restless legs syndrome induced by mirtazapine. J Clin Psychiatry. 2002 Dec;63(12):1179. PubMed PMID: 12530413.
29.Hargrave, R, Beckley, DJ. Restless leg syndrome exacerbated by sertraline. Psychosomatics. 1998 Mar-Apr;39(2):177–8. PubMed PMID: 9584547.
30.Bahk, WM, Pae, CU, Chae, JH, Jun, TY, Kim, KS. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci. 2002 Apr;56(2):209–10. PubMed PMID: 11952928.
31.Bonin, B, Vandel, P, Kantelip, JP. Mirtazapine and restless leg syndrome: a case report. Therapie. 2000 Sep-Oct;55(5):655–6. PubMed PMID: 11201984.
32.Pae, CU, Kim, TS, Kim, JJ, Chae, JH, Lee, CU, Lee, SJ, et al. Re-administration of mirtazapine could overcome previous mirtazapine-associated restless legs syndrome? Psychiatry Clin Neurosci. 2004 Dec;58(6):669–70. PubMed PMID: 15601394.
33.Kim, SW, Shin, IS, Kim, JM, Park, KH, Youn, T, Yoon, JS. Factors potentiating the risk of mirtazapine-associated restless legs syndrome. Hum Psychopharmacol. 2008 Oct;23(7):615–20. PubMed PMID: 18756499.
34.Brown, LK, Dedrick, DL, Doggett, JW, Guido, PS. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med. 2005 Sep;6(5):443–50. PubMed PMID: 16084763.
35.Dimmitt, SB, Riley, GJ. Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms. Arch Intern Med. 2000 Mar 13;160(5):712. PubMed PMID: 10724062.
36.Leutgeb, U, Martus, P. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. Eur J Med Res. 2002 Aug 30;7(8):368–78. PubMed PMID: 12204845.
37.Berger, K. Non-opioid analgesics and the risk of restless leg syndrome-a spurious association? Sleep Med. 2003 Jul;4(4):351–2. PubMed PMID: 14592311.
38.Ohayon, MM, Roth, T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002 Jul;53(1):547–54. PubMed PMID: 12127170.
39.Rottach, KG, Schaner, BM, Kirch, MH, Zivotofsky, AZ, Teufel, LM, Gallwitz, T, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res. 2008 Nov;43(1):70–5. PubMed PMID: 18468624.
40.Winkelmann, J, Prager, M, Lieb, R, Pfister, H, Spiegel, B, Wittchen, HU, et al. “Anxietas tibiarum”. Depression and anxiety disorders in patients with restless legs syndrome. J Neurol. 2005 Jan;252(1):6771. PubMed PMID: 15654556.
41.Picchietti, D, Winkelman, JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005 Jul;28(7):891–8. PubMed PMID: 16124671.
42.Bayard, M, Bailey, B, Acharya, D, Ambreen, F, Duggal, S, Kaur, T, et al. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2011 Jul-Aug;24(4):422–8. PubMed PMID: 21737767.
43.Goldstein, JM. The new generation of antipsychotic drugs: how atypical are they? Int J Neuropsychopharmacol. 2000 Dec;3(4):339–49. PubMed PMID: 11343614.
44.Kang, SG, Park, YM, Choi, JE, Lim, SW, Lee, HJ, Lee, SH, et al. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. Hum Psychopharmacol. 2010 Jul;25(5):397403. PubMed PMID: 20589923.
45.Horiguchi, J, Yamashita, H, Mizuno, S, Kuramoto, Y, Kagaya, A, Yamawaki, S, et al. Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome. Int Clin Psychopharmacol. 1999 Jan;14(1):33–6. PubMed PMID: 10221640. Epub 1999/04/30. eng.
46.Terao, T, Yoshimura, R, Terao, M, Yasumatsu, S, Ohmori, O, Shiratsuchi, T, et al. Restless legs syndrome induced by psychotropics. Ann Clin Psychiatry. 1992;4(2):127–30.
47.Akpinar, S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol. 1982 Nov;39(11):739. PubMed PMID: 7126008.
48.Duggal, HS, Mendhekar, DN. Clozapine-associated restless legs syndrome. J Clin Psychopharmacol. 2007 Feb;27(1):8990. PubMed PMID: 17224721. Epub 2007/01/17. eng.
49.Kraus, T, Schuld, A, Pollmacher, T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol. 1999 Oct;19(5):478–9. PubMed PMID: 10505594. Epub 1999/10/03. eng.
50.Wetter, TC, Brunner, J, Bronisch, T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry. 2002 May;35(3):109–11. PubMed PMID: 12107855. Epub 2002/07/11. eng.
51.Pinninti, NR, Mago, R, Townsend, J, Doghramji, K. Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psychopharmacol. 2005 Dec;25(6):617–8. PubMed PMID: 16282854. Epub 2005/11/12. eng.
52.Urbano, MR, Ware, JC. Restless legs syndrome caused by quetiapine successfully treated with ropinirole in 2 patients with bipolar disorder. J Clin Psychopharmacol. 2008 Dec;28(6):704–5. PubMed PMID: 19011442. Epub 2008/11/18. eng.
53.Kang, SG, Lee, HJ, Kim, L. Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine. J Psychopharmacol. 2009 Jul;23(5):597601. PubMed PMID: 18562412. Epub 2008/06/20. eng.
54.Khalid, I, Rana, L, Khalid, TJ, Roehrs, T. Refractory restless legs syndrome likely caused by olanzapine. J Clin Sleep Med. 2009 Feb 15;5(1):68–9. PubMed PMID: 19317385. Pubmed Central PMCID: 2637170. Epub 2009/03/26. eng.
55.Rittmannsberger, H, Werl, R. Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature. Int J Neuropsychopharmacol. 2013 Jul;16(6):1427–31. PubMed PMID: 23331473.
56.Bolanos-Vergaray, J, Obaya, JC, Gonzalez, R, Echeverri, C, Piquer, P. Restless legs syndrome due to aripiprazole. Eur J Clin Pharmacol. 2011 May;67(5):539–40. PubMed PMID: 21104073.
57.Webb, J. Co-occurring akathisia and restless legs syndrome likely induced by quetiapine. J Neuropsychiatry Clin Neurosci. 2012 Spring;24(2):E46–7. PubMed PMID: 22772702.
58.Raveendranathan, D, Shiva, L, Venkatasubramanian, G, Rao, MG, Varambally, S, Gangadhar, BN. Clozapine-induced restless legs syndrome treated with aripiprazole. J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):E62–3. PubMed PMID: 23686071.
59.Aggarwal, S, Dodd, S, Berk, M. Restless leg syndrome associated with olanzapine: a case series. Curr Drug Saf. 2010 Apr;5(2):129–31. PubMed PMID: 20406161.
60.Kang, SG, Lee, HJ, Jung, SW, Cho, SN, Han, C, Kim, YK, et al. Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1078–83. PubMed PMID: 17459547.
61.Jagota, P, Asawavichienjinda, T, Bhidayasiri, R. Prevalence of neuroleptic-induced restless legs syndrome in patients taking neuroleptic drugs. J Neurol Sci. 2012 Mar 15; 314 (1–2): 158–60. PubMed PMID: 22099638.
62.Kang, SG, Lee, HJ, Choi, JE, Park, YM, Park, JH, Han, C, et al. Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Neuropsychobiology. 2008; 57 (1–2): 4954. PubMed PMID: 18451638.
63.Desautels, A, Turecki, G, Montplaisir, J, Brisebois, K, Sequeira, A, Adam, B, et al. Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology. 2002 Jul 23;59(2):215–9. PubMed PMID: 12136060.
64.Winkelmann, J, Schadrack, J, Wetter, TC, Zieglgansberger, W, Trenkwalder, C. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med. 2001 Jan;2(1):5761. PubMed PMID: 11152983.
65.Drotts, DL, Vinson, DR. Prochlorperazine induces akathisia in emergency patients. Ann Emerg Med. 1999 Oct; 34 (4 Pt 1): 469–75. PubMed PMID: 10499947.
66.Parlak, I, Atilla, R, Cicek, M, Parlak, M, Erdur, B, Guryay, M, et al. Rate of metoclopramide infusion affects the severity and incidence of akathisia. Emerg Medicine J. 2005 Sep;22(9):621–4. PubMed PMID: 16113179. Pubmed Central PMCID: 1726928.
67.Erro, R, Amboni, M, Allocca, R, Santangelo, G, Barone, P, Vitale, C. Hemi-restless legs syndrome induced by clebopride. Eur J Neurol. 2012 Jun;19(6):e59. PubMed PMID: 22577755.
68.Tosini, G, Dirden, JC. Dopamine inhibits melatonin release in the mammalian retina: in vitro evidence. Neurosci Lett. 2000 Jun 2;286(2):119–22. PubMed PMID: 10825651.
69.Lewy, AJ, Wehr, TA, Goodwin, FK, Newsome, DA, Markey, SP. Light suppresses melatonin secretion in humans. Science. 1980 Dec 12;210(4475):1267–9. PubMed PMID: 7434030.
70.Whittom, S, Dumont, M, Petit, D, Desautels, A, Adam, B, Lavigne, G, et al. Effects of melatonin and bright light administration on motor and sensory symptoms of RLS. Sleep Med. 2010 Apr;11(4):351–5. PubMed PMID: 20226733.
71.Drake, ME. Restless legs with antiepileptic drug therapy. Clin Neurol Neurosurg. 1988;90(2):151–4. PubMed PMID: 3145164.
72.Chen, JT, Garcia, PA, Alldredge, BK. Zonisamide-induced restless legs syndrome. Neurology. 2003 Jan 14;60(1):147. PubMed PMID: 12525743.
73.Velasco, PE, Goiburu, JA, Pinel, RS. Restless legs syndrome induced by zonisamide. Mov Disord. 2007 Jul 30;22(10):1517–8. PubMed PMID: 17486608.
74.Romigi, A, Izzi, F, Placidi, F, Sperli, F, Cervellino, A, Marciani, MG. Topiramate-induced restless legs syndrome: a report of two cases. J Neurol. 2007 Aug;254(8):1120–1. PubMed PMID: 17473947.
75.Bermejo, PE. Restless legs syndrome induced by topiramate: two more cases. J Neurol. 2009 Apr;256(4):662–3. PubMed PMID: 19444538.
76.Okada, M, Kaneko, S, Hirano, T, Mizuno, K, Kondo, T, Otani, K, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res. 1995 Nov;22(3):193205. PubMed PMID: 8991786.
77.Silverdale, MA, Nicholson, SL, Crossman, AR, Brotchie, JM. Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson’s disease. Mov Disord. 2005 Apr;20(4):403–9. PubMed PMID: 15593312.
78.Johnson, BA. Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence? Addict Behav. 2004 Sep;29(7):1465–79. PubMed PMID: 15345276.
79.Garcia-Borreguero, D, Ferini-Strambi, L, Kohnen, R, O’Keeffe, S, Trenkwalder, C, Hogl, B, et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol. 2012 Nov;19(11):1385–96. PubMed PMID: 22937989.
80.Trenkwalder, C, Hening, WA, Montagna, P, Oertel, WH, Allen, RP, Walters, AS, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008 Dec 15;23(16):2267–302. PubMed PMID: 18925578.
81.Trenkwalder, C, Benes, H, Grote, L, Garcia-Borreguero, D, Hogl, B, Hopp, M, et al. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013 Dec;12(12):1141–50. PubMed PMID: 24140442.
82.Vetrugno, R, La Morgia, C, D’Angelo, R, Loi, D, Provini, F, Plazzi, G, et al. Augmentation of restless legs syndrome with long-term tramadol treatment. Mov Disord. 2007 Feb 15;22(3):424–7. PubMed PMID: 17230457.
83.Earley, CJ, Allen, RP. Restless legs syndrome augmentation associated with tramadol. Sleep Med. 2006 Oct;7(7):592–3. PubMed PMID: 16926116.
84.Garcia-Borreguero, D, Kohnen, R, Silber, MH, Winkelman, JW, Earley, CJ, Hogl, B, et al. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med. 2013 Jul;14(7):675–84. PubMed PMID: 23859128.
85.Terao, T, Terao, M, Yoshimura, R, Abe, K. Restless legs syndrome induced by lithium. Biol Psychiatry. 1991 Dec 1;30(11):1167–70. PubMed PMID: 1777530.
86.Heiman, EM, Christie, M. Lithium-aggravated nocturnal myoclonus and restless legs syndrome. Am J Psychiatry. 1986 Sep;143(9):1191–2. PubMed PMID: 3752305.
87.LaRochelle, JS, Karp, BI. Restless legs syndrome due to interferon-alpha. Mov Disord. 2004 Jun;19(6):730–1. PubMed PMID: 15197722.
88.Inal, S, Golbas, C, Onec, K, Okyay, GU, Derici, UB. Methoxy polyethylene glycol-epoetin beta (CERA) induced restless legs syndrome. Ther Apher Dial. 2012 Aug;16(4):378–9. PubMed PMID: 22817128.
89.Tan, EK, Ho, SC, Koh, L, Pavanni, R. An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation. Mov Disord. 2004 Nov;19(11):1365–7. PubMed PMID: 15378680.
90.Santamaria, J, Iranzo, A, Tolosa, E. Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep. Sleep Med. 2003 Mar;4(2):153–5. PubMed PMID: 14592347.
91.Garcia-Borreguero, D, Williams, AM. Dopaminergic augmentation of restless legs syndrome. Sleep Medicine Rev. 2010 Oct;14(5):339–46. PubMed PMID: 20219397.
92.Garcia-Borreguero, D, Hogl, B, Ferini-Strambi, L, Winkelman, J, Hill-Zabala, C, Asgharian, A, et al. Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks. Mov Disord. 2012 Feb;27(2):277–83. PubMed PMID: 22328464.
93.Allen, RP, Ondo, WG, Ball, E, Calloway, MO, Manjunath, R, Higbie, RL, et al. Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med. 2011 May;12(5):431–9. PubMed PMID: 21493132.
94.Chokroverty, S. Long-term management issues in restless legs syndrome. Mov Disord. 2011 Jul;26(8):1378–85. PubMed PMID: 21538518.
95.Winkelman, JW, Johnston, L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med. 2004 Jan;5(1):914. PubMed PMID: 14725821.
96.Benes, H, Heinrich, CR, Ueberall, MA, Kohnen, R. Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. Sleep. 2004 Jun 15;27(4):674–82. PubMed PMID: 15283002.
97.Trenkwalder, C, Benes, H, Grote, L, Happe, S, Hogl, B, Mathis, J, et al. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial. Mov Disord. 2007 Apr 15;22(5):696703. PubMed PMID: 17274039.
98.Benes, H, Garcia-Borreguero, D, Ferini-Strambi, L, Schollmayer, E, Fichtner, A, Kohnen, R. Augmentation in the treatment of restless legs syndrome with transdermal rotigotine. Sleep Med. 2012 Jun;13(6):589–97. PubMed PMID: 22503658.
99.Hogl, B, Garcia-Borreguero, D, Kohnen, R, Ferini-Strambi, L, Hadjigeorgiou, G, Hornyak, M, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol. 2010 Feb;257(2):230–7. PubMed PMID: 19756826. Pubmed Central PMCID: 3085743.
100.Ondo, W, Romanyshyn, J, Vuong, KD, Lai, D. Long-term treatment of restless legs syndrome with dopamine agonists. Arch Neurol. 2004 Sep;61(9):1393–7. PubMed PMID: 15364685.
101.Garcia-Borreguero, D, Allen, RP, Kohnen, R, Hogl, B, Trenkwalder, C, Oertel, W, et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007 Aug;8(5):520–30. PubMed PMID: 17544323.
102.Guilleminault, C, Cetel, M, Philip, P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology. 1993 Feb;43(2):445. PubMed PMID: 8094897.
103.Walters, AS, Hening, W, Rubinstein, M, Chokroverty, S. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. Sleep. 1991 Aug;14(4):339–45. PubMed PMID: 1682986. Epub 1991/08/01. eng.
104.Paulus, W, Trenkwalder, C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol. 2006 Oct;5(10):878–86. PubMed PMID: 16987735.